Atomoxetine and Nausea and vomiting - a phase IV clinical study of FDA data

Summary:

Nausea and vomiting is reported as a side effect among people who take Atomoxetine (atomoxetine), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Lamictal, and have Migraine.

The phase IV clinical study analyzes which people have Nausea and vomiting when taking Atomoxetine. It is created by eHealthMe based on reports of 1,183 people who have side effects when taking Atomoxetine from the FDA, and is updated regularly.

What is Atomoxetine?

Atomoxetine has active ingredients of atomoxetine. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,363 Atomoxetine users. Check the latest studies of Atomoxetine.

What is Nausea and vomiting?

Nausea and vomiting is found to be associated with 3,692 drugs and 5,743 conditions by eHealthMe. Check the latest studies of Nausea and vomiting.

On Jul, 03, 2026

1,183 people reported to have side effects when taking Atomoxetine.
Among them, 70 people (5.92%) have Nausea and vomiting.

Could Atomoxetine cause Nausea and vomiting?

Among these 70 people:

How long have people been on Atomoxetine when they have Nausea and vomiting? *

What is the gender of people who have Nausea and vomiting when taking Atomoxetine? *

female: 54.1 %
male: 45.9 %

What is the age of people who have Nausea and vomiting when taking Atomoxetine? *

What are other drugs people take besides Atomoxetine? *

What are other side effects people have besides Nausea and vomiting? *

Nausea (feeling of having an urge to vomit): 29 people, 41.43%
Abdominal Pain Upper: 28 people, 40.00%
Drug Ineffective: 25 people, 35.71%
Migraine (headache): 24 people, 34.29%
Pain: 24 people, 34.29%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 24 people, 34.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 23 people, 32.86%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 23 people, 32.86%
Drug Intolerance (drug sensitivity): 23 people, 32.86%
Memory Loss: 23 people, 32.86%

What are the existing conditions these people have? *

Migraine (headache): 23 people, 32.86%
Constipation: 14 people, 20.00%
Growth Hormone-Producing Pituitary Tumor: 14 people, 20.00%
Pituitary Tumor: 14 people, 20.00%
Tremor (trembling or shaking movements in one or more parts of your body): 7 people, 10.00%
Rickets (softening of bones): 2 people, 2.86%
Autoimmune Hepatitis: 2 people, 2.86%
Disturbance In Attention: 2 people, 2.86%
Itching: 2 people, 2.86%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 2 people, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Atomoxetine and have Nausea and vomiting?

- Check whether Nausea and vomiting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atomoxetine:

Atomoxetine (1,363 reports)

Browse all side effects of Atomoxetine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea and vomiting:

Nausea and vomiting (3,692 drugs)

Browse all the conditions that are associated with Nausea and vomiting:

Nausea and vomiting (5,743 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine (the active ingredients of Atomoxetine) and Atomoxetine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.